Archive for March, 2023

More Window Dressing: Blumenthal Announces New Federal Funding For Tick Research

https://www.wshu.org/connecticut-news/2023-03-24/blumenthal-announces-new-federal-funding-for-tick-research

Blumenthal announces new federal funding for tick research

Blumenthal

Molly Ingram/WSHU  U.S. Senator Richard Blumenthal holds a tick, swollen from drinking blood.

U.S. Senator Richard Blumenthal (D-CT) has announced millions of dollars in funding for research into tick-borne diseases.

Diseases caused by ticks have more than doubled in the last ten years across the Northeast.

The Connecticut Agricultural Experiment Station, located in New Haven, will receive $200,000.

Blumenthal said the money will fund vital research at the nationally recognized facility.

(See link for article)

________________

SUMMARY:

  • Money to New Haven will be used to hire staff for testing ticks
  • $26 Million will go to the corrupt CDC to study Lyme disease
  • $7 Million will go to the complicit DOD‘s Tick-borne Disease Research Program

In the words of Willy Burgdorfer, the “discoverer” of Lyme:

“The controversy in Lyme Disease research is a shameful affair.  I say that because the whole thing is politically tainted.  Money goes to people that have for the past 30 years produced the same thing.  Nothing.” ~ Dr. Willy Burgdorferi

Money lining the pockets of the same people in corrupt agencies will come to nothing.
Mark my words.

For more:

New Documentary Explores Lyme Disease Controversies

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/31429431

THINK OUT LOUD; New documentary explores Lyme disease controversies

Carl Tuttle

Hudson, NH, United States

MAR 23, 2023 — 

Today’s letter… The Oregon Public Broadcasting interview below with Winslow Crane-Murdoch, co-director of the Quiet Epidemic is worth the read.

https://www.opb.org/article/2023/03/08/lyme-disease-quiet-epidemic-documentary/

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “thinkoutloud@opb.org” <thinkoutloud@opb.org>
Cc: “dmiller@opb.org” <dmiller@opb.org>, “opbnews@opb.org” <opbnews@opb.org>, “svanwing@opb.org” <svanwing@opb.org>, “mholm@opb.org” <mholm@opb.org>, “abarrett@utmb.edu” <abarrett@utmb.edu>, “R.W.Titball@exeter.ac.uk” <R.W.Titball@exeter.ac.uk>, “kait@thequietepidemic.com” <kait@thequietepidemic.com>, “lindsay@thequietepidemic.com” <lindsay@thequietepidemic.com>, “Raymond_Dattwyler@nymc.edu” <Raymond_Dattwyler@nymc.edu>
Date: 03/22/2023 9:27 AM

Subject: THINK OUT LOUD; New documentary explores Lyme disease controversies

New documentary explores Lyme disease controversies
https://www.opb.org/article/2023/03/08/lyme-disease-quiet-epidemic-documentary/
By Sage Van Wing (OPB)  March 8, 2023

“The medical community has been slow to recognize this form of long-lasting [Chronic] Lyme disease and to find treatments for it”

Oregon Public Broadcasting
THINK OUT LOUD
Attn: Dave Miller, Host

Dear Mr. Miller,

Thank you for interviewing Winslow Crane-Murdoch, co-director of the Quiet Epidemic.

I spent the last thirteen years studying the mishandling of Lyme disease as an independent researcher whose entire family progressed to late-stage Lyme before we knew what went wrong with our health. I can say with 100% confidence that the rush to create a vaccine led to the denial of persistent infection after the one-size-fits-all IDSA treatment guideline; chronic Lyme disease.

Please see the inquiry below addressed to Dr. Raymond Dattwyler who owns 24 patents that include diagnostic testing and Lyme vaccines (OspA) both live bacteria and oral. Maria Gomes-Solecki (co-author of this publication) is co-owner to 17 of those patents.

A new OspA vaccine has been fast tracked by the FDA. The previous OspA vaccine LYMErix was pulled from the market in 2002 not solely due to low demand per the following report.

REPORT ON LYMErix prepared for the 2001 Advisory Committee Meeting:(personal Dropbox storage area)
https://www.dropbox.com/s/sodqs3pdeeesktf/Sheller%20Lymerix.pdf?dl=0

Excerpt

“The people who have contacted us were, prior to vaccination with LYMErix, healthy, active and energetic. Indeed, the very reason they sought the LYMErix vaccine was their desire to preserve their healthy, active lifestyle. However, what they experienced was a dramatic degradation of their health and quality of life. As will be described below, these previously healthy individuals are now afflicted with painful, at times debilitating arthritic symptoms, including joint pain and swelling, as well as extremely severe Lyme-disease-like symptoms which have persisted to this day.”

Below is the link to the Final Judgement and Approval of the class action against SmithKline Beecham as a settlement was awarded to these individuals.

JUDGEMENT, FINAL ORDER AND DECREE GRANTING FINAL APPROVAL OF THE CLASS ACTION SETTLEMENT: (personal Dropbox storage area)
https://www.dropbox.com/s/v3gyw4fv8nst9bz/2003_Vaccine_Judgement_Final_Sttle_Apprvl..pdf?dl=0

In addition, there were neurological complications with LYMErix as published in the International Journal of Risk & Safety in Medicine. Reports of cerebral ischemia, transient Ischemic attacks, demyelinating events, optic neuritis, transverse myelitis, and non-specific demyelinating conditions are evaluated in this paper:

Neurological complications of vaccination with outer surface protein A (OspA).
Marks DH
http://www.ncbi.nlm.nih.gov/pubmed/21673416

2023 Announcement for the current OspA vaccine: (is history about to repeat itself?)

Western New York kids are eligible to get a Lyme disease vaccine through Pfizer clinical study conducted at UB
https://www.buffalo.edu/news/releases/2023/03/015.html

Mr. Miller,

An astute fifth grader with access to PubMed could find the references I provided to Dr. Dattwyler in my email below.

A chronic relapsing seronegative disease does not fit the business model of vaccine development, patent royalties and pharmaceutical profits. You cannot prove vaccine efficacy when we do not know who has or does not have the disease.

For the record, Dattwyler refused to respond to my inquiry so perhaps you could reach out to him for comment. I have taken the liberty to carbon copy Dr. Dattwyler along with Alan D.T. Barrett, PhD Editor-in-Chief of npj Vaccines.

Respectfully submitted,

Carl Tuttle
Hudson, NH

Inquiry to Dr. Raymond Dattwyler:

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: Raymond_Dattwyler@nymc.edu
Cc: npjvaccines@nature.com, abarrett@utmb.edu, R.W.Titball@exeter.ac.uk, mgomesso@uthsc.edu
Date: 01/06/2023 2:46 PM
Subject: The year that shaped the outcome of the OspA vaccine for human Lyme disease

npj Vaccines Jan 2022

The year that shaped the outcome of the OspA vaccine for human Lyme disease
https://www.nature.com/articles/s41541-022-00429-5
Raymond J. Dattwyler & Maria Gomes-Solecki

Department of Microbiology and Immunology
New York Medical College
Valhalla, NY
Raymond J. Dattwyler, Corresponding Author

Dear Dr. Dattwyler,

I read your manuscript with great interest as you call attention to a treatment-resistant Lyme arthritis with “no evidence of DNA” found in the joints of patients after antibiotic treatment.

For some strange reason however, I could not find the following 1995 publication within your paper identifying treatment-resistant neuroborreliosis:

European Neurology 1995

Seronegative Chronic Relapsing Neuroborreliosis
https://www.karger.com/Article/Abstract/117104

Lawrence C., Lipton R.B., Lowy F.D., Coyle P.K.d

Abstract

We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen.

In fact, Dr. Dattwyler there seems to be a great deal of “treatment-resistant” evidence published in multiple journals over the past three decades:

Peer Reviewed Evidence of Persistence of Lyme Disease Spirochete Borrelia burgdorferi and Tick-Borne Diseases (700 References)
https://www.dropbox.com/s/n09sk90eo6xz7ua/700%20articles%20LYME%20EvidenceofPersistence-V2.pdf?dl=0

So that brings me to the reason for this email…

Question:  Does a chronic relapsing seronegative disease fit the vaccine model? If not, would that, in and of itself, be the hidden reason for denying chronic (treatment-resistant) Lyme disease for almost three decades?  In other words, patent royalties and pharmaceutical profits over lifesaving care?

A response to this inquiry is requested.

Carl Tuttle
Hudson, NH

Cc: Alan D.T. Barrett, PhD Editor-in-Chief
Rick Titball, PhD, DSc, Deputy Editor

Letter to the Editor of the BMJ published June 2020
https://www.bmj.com/content/369/bmj.m1041/rr-1

For more:

WHO – Rotting From the Head

This website has posted prolifically on the corrupt WHO which is attempting to garner even more power through a dystopian, legally binding pandemic treaty which supersedes the Constitution, and which would rule all life on earth if passed.  The organization has a strong allegiance to China and Big Pharma, and is funded primarily by Bill Gates.

https://www.malcolmrobertsqld.com.au/world-health-organisation-is-rotting-from-the-head/

WORLD HEALTH ORGANIZATION IS ROTTING FROM THE HEAD

March 9, 2023

http://  Approx. 2 Min

“WHO is Rotting From the Head” ~ Australian Senator Malcolm Roberts

Former terrorist Tedros Ghebreyesus will not fire 83 WHO staff engaged in abuse including rape and forced abortions, with one victim 13, claiming rape and forced abortion do not violate WHO’s policies because the victims were not receiving WHO aid.
Transcript

Last year the Albanese government continued the Morrison government’s campaign to sign away Australian sovereignty to the United Nations World Health Organization, the WHO. Despite the attempt failing, WHO’s power grab is ongoing.

The WHO is not independent. Their owners are corporate donors who contribute most of the WHO budget. WHO’s current sugar daddy is Bill Gates, who has made billions out of his investment in the same vaccines that WHO promotes. Gates bought the WHO and they now recommend his products. It is that simple.

The head of the WHO is Tedros Ghebreyesus, who was previously the health minister of a terrorist organization called the Tigray People’s Liberation Front and used international aid to buy power and punish his enemies. The regions of Ethiopia that Tedros starved of medical supplies suffered disastrous cholera epidemics in 2006, 2009 and 2011. Independent investigators found Tedros was ‘fully complicit in the terrible suffering and dying that continues to spread in East Africa.’ He’s a killer. WHO is rotting from the head.

Last week, Associated Press reported on the WHO sex crimes scandal, where WHO staffers sexually exploited girls and women during the Congo’s recent Ebola outbreak—inhuman. At least 83 WHO staff engaged in abuse, including rape and forced abortions, with victims as young as 13. WHO refused to fire the perpetrators, using the absurd argument that their actions didn’t violate WHO’s sexual exploitation practice policies because the victims were not receiving WHO aid; the raping part is okay with Tedros. This the person who heads an organisation that many in government and academia want to elevate above the Australian parliament.

One Nation rejects the UN-WHO power grab and will defend Australia’s sovereignty. So should you all.

Alarming GI Damage Post COVID Shot

https://rumble.com/v2ehywu–dr.-sabine-hazan-on-the-alarming-damage-observed-in-gi-bacteria-post-vacci.html  Video Here (Approx. 3 Min)

Dr. Sabine Hazan on the Alarming Damage Observed in GI Bacteria Post-Vaccination

“Their bifidobacteria dropped to like zero—from like a million to like zero…There was a persistence in the damage, not only 90 days but 6-9 months later.”

“First of all, there was no way I was going to publish this cuz nobody would have taken that so I decided to submit it to the American College of Gastro as a presentation, as a poster.” ~ Dr. Sabine Hazan, Gastroenterology specialist with over 31 years experience

Bifidobacteria is one of the major phyla and most abundant genera in the healthy intestinal tract of humans and is even more pronounced in infants, especially during lactation, when it constitutes a majority of the total bacterial population. One of the early pioneering colonizers of the early gut microbiota it plays important roles in the metabolism of dietary components otherwise indigestible in the upper intestine and in the maturation of the immune system.  It also interacts with human immune cells and modulates specific pathways involving innate and adaptive immune processes.  Source

Hazen speculates that the reason for the lack of bifidobacteria is due to the COVID injections creating bacteriophages or bifidophages.

She also discovered that this bacteria is completely missing in breast-feeding infants of mothers who got the gene therapy injections.

  • Hazen coauthored a paper that found that low bacterial diversity and depletion of Bifidobacterium genera either before or after infection led to reduced proimmune function, thereby allowing SARS-CoV-2 infection to become symptomatic. This particular dysbiosis pattern may be a susceptibility marker for symptomatic severity from SARS-CoV-2 infection and may be amenable to preinfection, intrainfection or postinfection intervention.
  • She also coauthored the book, “Let’s Talk SH!T: Disease Digestion & Fecal Transplants.”
  • In 2021 the NIH reconsidered ivermectin as a possible treatment for COVID due to the Ventura Clinical Trials, owned and operated by Hazan, which found ivermectin and HCQ were remarkably successful in treating COVID.

Two Duke Law Students Launch Pro Bono Lyme Advocacy Project

https://www.lymedisease.org/duke-law-lyme-advocacy-project/

Two Duke law students launch pro bono Lyme advocacy project

March 22, 2023

We, Luke Mears and Madison Pinckney, founded the Duke Law Lyme Disease Advocacy Project (LDAP) in 2022.

In creating the group, we hope to improve the lives of Lyme disease patients by partnering with nonprofit organizations that work on legislative advocacy and lawsuits centered on Lyme.

Madison’s Lyme story

I contracted Lyme at about nine years old, but I wasn’t diagnosed for another 10 years. I grew up in and out of doctors’ offices, searching for answers that always seemed to be “that’s normal.”

While I was deteriorating during a severe flare in 2018, my mom’s research led to finding a Lyme specialist. While filling out the symptom questionnaire in the doctor’s office, I kept pointing to a symptom and asking my mom, “that doesn’t happen to you?”

After being properly diagnosed with multiple tick-borne infections, I found rapid relief of many symptoms, but other persisted.

Throughout the past five years of flares and treatment, I’ve seen the frustration and inequities of being a Lyme patient. I focused my advocacy work on being a mentor, starting a podcast, and lobbying for increased federal funding. In 2021, I saw drastic symptom improvement and took advantage by starting law school at Duke University, hoping to make a difference for Lyme patients and those with disabilities.

Luke’s Lyme story

I was diagnosed with Lyme disease in 2020, only a few weeks after being sent home from my undergraduate institution due to the Covid-19 pandemic.  I remember being more tired than I ever had been and fighting a constant swing of anxiety attacks and mood swings. The pandemic did not make finding a medical provider easy, but after three weeks I got a doctor’s appointment.

Unfortunately, that appointment only led to a misdiagnosis, and it took multiple additional weeks to find a new doctor who was, after much testing, finally able to reach a diagnosis of Lyme disease. After weeks of antibiotic treatment, I began to feel better and improve. The ordeal remains one of the most stressful and painful experiences of my life, and the indifference and ignorance faced throughout made me want to make a difference in the Lyme disease space.

I briefly considered a public health degree instead of law, but I decided to follow my life dream of being a lawyer. Founding the Lyme Disease Advocacy Project here at Duke has allowed me to help others facing this disease, while also working toward larger societal improvements in awareness, prevention, and treatment of the disease.

The project’s formation and work

While sitting on her bed prepping for the Center for Lyme Action’s Virtual Fly-In the next day, Madison saw an email from Luke Mears to the Duke Law Class of 2024. He wanted to start a Lyme Disease Advocacy Project pro bono group at the law school at Duke. After an immediate reply, followed by discussion of their shared experiences, LDAP began to take shape.

Not only was it cathartic to find someone in such a small community who had experienced similar pain, it was even better to find someone who shared our passion for making in difference in this disease. As two individuals healed enough to attend law school, we felt a responsibility to give back to those still waiting for a diagnosis or helpful treatment.

LDAP began a trial period in the spring of 2022 and received great support. During a hectic time, the month before finals, we received interest from numerous volunteers and were able to connect with other classmates affected by Lyme as well.

Becoming official

More than ten students completed over 60 hours of pro bono work, researching and writing about legislative questions and issues regarding Lyme disease. The first research projects completed by our nonprofit partners spurred the project’s growth and LDAP became an official Duke Law pro bono project in the summer of 2022.

This year, we’ve expanded the project and our partners, aiming to provide legal and advocacy assistance across the country.

Some of our work has focused on the relationships between health agencies, policies on including Lyme disease information on government websites, and Lyme vaccine development.

At the halfway mark of the semester, over a dozen students have completed over 70 hours of pro bono work relating to Lyme disease. With these students continuing to work on various projects, we estimate that our ambitious goal of doing 150 hours of pro bono work relating to Lyme disease should be realized by the end of the semester.

Through this project, we are utilizing the incredible resources we have access to and sharing the skills we’ve learned while at Duke. As LDAP continues, we’re proud of everything our volunteers can do to further the fight for change. We’re grateful to Duke University’s School of Law and all our partners for giving us the opportunity to work for the benefit of the Lyme community.

_______________

**Food For Thought**

This is the first I’ve heard of this work, so I don’t pretend to understand everything they are attempting to do other than what is stated in this brief article.  That said, it is my experience that many with a sincere desire to help the Lyme/MSIDS community are uneducated about the sordid backstory of government deception – including fraud, corruption, and underhanded manipulation at every turn, conflicts of interest, and the ongoing yet fruitless attempts to work with these same corrupt government agencies.

This backstory is foundational to know in order to move forward wisely.  Not knowing and understanding this backstory means more time, effort, and money will be wasted, and a lot has already been wasted.

When I read that their efforts include:

  • relationships between health agencies
  • policies on including Lyme disease information on government websites
  • Lyme vaccine development
I am immediately skeptical.
  1. a relationship with any federal health agency has been a complete and utter waste of time, historically
  2. information on government websites will never change until the accepted, government dictated paradigm changes.  It is my opinion that hell will freeze over before this happens.  I pray I’m wrong  
  3. Lyme “vaccine” development is dead in the water as far as I’m concerned until problems 1 & 2 are rectified because they are all intertwined. For instance, you can not have a “vaccine” for a chronic condition(s) and Lyme/MSIDS is just such an illness, which is also the reason ‘the powers that be’ will never admit in 1,000 years that Lyme/MSIDS is a persistent infection(s).  There’s too much money to be made in “vaccine” development and our government owns patents on many “vaccines” and receives royalties on said products.  This merry-go round has been spinning for over 40 years without end.  Further, coinfection involvement muddies the picture considerably and has still not been recognized and taken into account by the federal government and mainstream medicine.  Not only is it impossible to “vaccinated” for a chronic infection(s), it’s also impossible to “vaccinate” for numerous pathogens simultaneously that often work symbiotically, and it’s close to impossible to even accurately test for these infections to begin with.  There’s a bevy of problems that need to be addressed before the word “vaccine” should be even uttered.
  4. the emphasis is always on a “magic cure all” and rarely on effective treatments for the folks that are suffering now
I look at these young, fresh faces and worry that yet another well meaning exploit will result in frustration and stalemate.
I guess I’m showing my age.